Skip to main content

Correction to: Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells

The Original Article was published on 04 March 2021

Correction to: BMC Complement Med Ther 21, 83 (2021)

https://doi.org/10.1186/s12906-021-03246-w

Following publication of the original article [1], the authors identified an error in the affiliations ordering, the author name of Ahad Bazmani, and the affiliations of research center in the Acknowledgments section. Corrections are below:

Sanya Haiaty1,2, Mohammad-Reza Rashidi3, Maryam Akbarzadeh2,4, Ahad Bazmani5,6, Mostafa Mostafazadeh1,2, Saba Nikanfar1,2, Zohre Zibaei1,6, Reza Rahbarghazi3,7,8*† and Mohammad Nouri3,7*†

1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

2Department of Biochemistry and Clinical Laboratories, Tabriz University of Medical Sciences, Tabriz, Iran.

3Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

4Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.

5Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University Of Mashhad, Mashhad, Iran.

6Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

7Stem Cell Research Center, Tabriz University of Medical Sciences, Imam Reza St., Golgasht St, Tabriz, Iran.

8Departmnt of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

The incorrect author name is: Ahad Bazmany

The correct author name is: Ahad Bazmani

Acknowledgments

We special thanks to the Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences for their assistance in the progression of my thesis.

The original article [1] has been updated.

Reference

  1. 1.

    Haiaty S, Rashidi MR, Akbarzadeh M, et al. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells. BMC Complement Med Ther. 2021;21:83. https://doi.org/10.1186/s12906-021-03246-w.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Reza Rahbarghazi or Mohammad Nouri.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Haiaty, S., Rashidi, MR., Akbarzadeh, M. et al. Correction to: Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells. BMC Complement Med Ther 21, 266 (2021). https://doi.org/10.1186/s12906-021-03414-y

Download citation